$228.48
2.58%
NYSE, Wed, Sep 18 2024
ISIN
US03073E1055
Symbol
ABC

Cencora Stock price

$228.48
-10.37 4.34% 1M
-10.83 4.53% 6M
+23.10 11.25% YTD
+49.45 27.62% 1Y
+106.51 87.32% 3Y
+145.48 175.28% 5Y
+151.35 196.23% 10Y
NYSE, Closing price Wed, Sep 18 2024
-6.05 2.58%
ISIN
US03073E1055
Symbol
ABC
Sector

Key metrics

Market capitalization $46.21b
Enterprise Value $47.67b
P/E (TTM) P/E ratio 25.46
EV/FCF (TTM) EV/FCF 12.44
EV/Sales (TTM) EV/Sales 0.17
P/S ratio (TTM) P/S ratio 0.16
P/B ratio (TTM) P/B ratio 49.94
Dividend yield 0.87%
Last dividend (FY24) $2.04
Revenue growth (TTM) Revenue growth 11.56%
Revenue (TTM) Revenue $283.83b
EBIT (operating result TTM) EBIT $2.84b
Free Cash Flow (TTM) Free Cash Flow $3.83b
Cash position $3.41b
EPS (TTM) EPS $9.21
P/E forward 21.10
P/S forward 0.16
EV/Sales forward 0.16
Short interest 4.37%
Show more

Is Cencora a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,912 stocks worldwide.

Cencora Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Cencora forecast:

13x Buy
65%
6x Hold
30%
1x Sell
5%

Analyst Opinions

20 Analysts have issued a Cencora forecast:

Buy
65%
Hold
30%
Sell
5%

Financial data from Cencora

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
283,831 283,831
12% 12%
100%
- Direct Costs 275,430 275,430
12% 12%
97%
8,401 8,401
10% 10%
3%
- Selling and Administrative Expenses 4,455 4,455
3% 3%
2%
- Research and Development Expense - -
-
-
3,946 3,946
18% 18%
1%
- Depreciation and Amortization 1,110 1,110
29% 29%
0%
EBIT (Operating Income) EBIT 2,836 2,836
14% 14%
1%
Net Profit 1,856 1,856
10% 10%
1%

In millions USD.

Don't miss a Thing! We will send you all news about Cencora directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Cencora Stock News

Positive
Forbes
about one year ago
Walgreens Boots Alliance has sold shares of AmerisourceBergen for initial proceeds of $2.85 billion, which will be used to accelerate the drugstore giant's healthcare strategy.
Neutral
Reuters
about one year ago
Walgreens Boots Alliance has sold some AmerisourceBergen Corp's shares for proceeds of about $1.85 billion, the U.S. drugstore chain said on Thursday, further cutting its ownership in the drug distributor to about 16%.
Positive
Market Watch
about one year ago
Drugstore chain Walgreens Boots Alliance Inc. WBA, -1.17% on Thursday said it sold shares of drug distributor AmerisourceBergen Corp. ABC, -0.04% for initial proceeds of $1.85 billion. Walgreens said it planned to use the proceeds it got from the deal largely to pay down debt and to handle general operations.
More Cencora News

Company Profile

AmerisourceBergen Corp. engages provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes a comprehensive offering of brand-name, specialty brand-name & generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies & equipment, outsourced compounded sterile preparations, and related services to a wide variety of healthcare providers, including acute care hospitals and health systems, independent & chain retail pharmacies, mail order pharmacies, medical clinics, long-term care & alternate site pharmacies, and other customers. The Other segment focuses on global commercialization services and animal health and includes ABCS, World Courier, and MWI. The company was founded in 1947 and is headquartered in Chesterbrook, PA.

Head office United States
CEO Steven Collis
Employees 46,000
Founded 1947
Website www.cencora.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today